Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Apr 17:14:1150412.
doi: 10.3389/fmicb.2023.1150412. eCollection 2023.

Yeast oral vaccines against infectious diseases

Nicanor Austriaco  1
Affiliations
Review

Yeast oral vaccines against infectious diseases

Nicanor Austriaco. Front Microbiol. .

Abstract

Vaccines that are delivered orally have several advantages over their counterparts that are administered via injection. Despite the advantages of oral delivery, however, approved oral vaccines are currently limited either to diseases that affect the gastrointestinal tract or to pathogens that have a crucial life cycle stage in the gut. Moreover, all of the approved oral vaccines for these diseases involve live-attenuated or inactivated pathogens. This mini-review summarizes the potential and challenges of yeast oral vaccine delivery systems for animal and human infectious diseases. These delivery systems utilize whole yeast recombinant cells that are consumed orally to transport candidate antigens to the immune system of the gut. This review begins with a discussion of the challenges associated with oral administration of vaccines and the distinct benefits offered by whole yeast delivery systems over other delivery systems. It then surveys the emerging yeast oral vaccines that have been developed over the past decade to combat animal and human diseases. In recent years, several candidate vaccines have emerged that can elicit the necessary immune response to provide significant protection against challenge by pathogen. They serve as proof of principle to show that yeast oral vaccines hold much promise.

Keywords: Saccharomyces boulardii; Saccharomyces cerevisiae; oral vaccine; vaccine; vaccine adjuvant and delivery system; yeast.

PubMed Disclaimer

Conflict of interest statement

The author declares that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Alotaibi B. S., Buabeid M., Ibrahim N. A., Kharaba Z. J., Ijaz M., Murtaza G. (2021). Recent strategies driving oral biologic administration. Expert Rev. Vaccines 20, 1587–1601. doi: 10.1080/14760584.2021.1990044, PMID: - DOI - PubMed
    1. Ananphongmanee V., Lertpreedakorn N., Taengchaiyaphum S., Charoenrat T., Sritunyalucksana K., Boonchird C. (2021). Shrimp protected from a virus by feed containing yeast with a surface-displayed viral binding protein. J. Biotechnol. 342, 45–53. doi: 10.1016/j.jbiotec.2021.09.014, PMID: - DOI - PubMed
    1. Ananphongmanee V., Srisala J., Sritunyalucksana K., Boonchird C. (2015). Yeast surface display of two proteins previously shown to be protective against white spot syndrome virus (WSSV) in shrimp. PLoS One 10, 1–14. doi: 10.1371/journal.pone.0128764, PMID: - DOI - PMC - PubMed
    1. Arnold M., Durairaj V., Mundt E., Schulze K., Breunig K. D., Behrens S. E. (2012). Protective vaccination against infectious bursal disease virus with whole recombinant Kluyveromyces lactis yeast expressing the viral VP2 subunit. PLoS One 7:e42870. doi: 10.1371/JOURNAL.PONE.0042870, PMID: - DOI - PMC - PubMed
    1. Bagherpour G., Ghasemi H., Zand B., Zarei N., Roohvand F., Ardakani E. M., et al. . (2018). Oral Administration of Recombinant Saccharomyces boulardii expressing ovalbumin-CPE fusion protein induces antibody response in mice. Front. Microbiol. 9:723. doi: 10.3389/fmicb.2018.00723, PMID: - DOI - PMC - PubMed